Report error Found 1154 Enz. Inhib. hit(s) with Target = 'Dual specificity protein kinase CLK2'
Affinity DataKd: 1.80E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 1.10E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 1.70E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 1.80E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 2.20E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 290nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 420nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 3.20E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 860nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 700nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 150nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 8.20nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 20nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 318nMAssay Description:Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged CLK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells i...More data for this Ligand-Target Pair
Affinity DataKd: 396nMAssay Description:Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged CLK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells i...More data for this Ligand-Target Pair
Affinity DataKd: <100nMAssay Description:Binding affinity to CLK2 (unknown origin)More data for this Ligand-Target Pair
Affinity DataKd: 220nMAssay Description:Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system measured after 1 hr by compe...More data for this Ligand-Target Pair
Affinity DataKd: 460nMAssay Description:Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system by Kinomescan method relative to c...More data for this Ligand-Target Pair
Affinity DataKd: 0.900nMAssay Description:Inhibition of human partial length CLK2 (D144/R498) expressed in bacterial system by DiscoveryX Kinomescan binding assayMore data for this Ligand-Target Pair
Affinity DataKd: 19nMAssay Description:Binding affinity to CLK2 (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
Affinity DataKd: 0.0960nMAssay Description:Binding affinity to CLK2 (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
Affinity DataKd: 0.0960nMAssay Description:Binding affinity to CLK2 (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
Affinity DataKd: 12nMAssay Description:Average Binding Constant for CLK2; NA=Not Active at 10 uMMore data for this Ligand-Target Pair
Affinity DataKd: 300nMAssay Description:Average Binding Constant for CLK2; NA=Not Active at 10 uMMore data for this Ligand-Target Pair
Affinity DataKd: 1.90E+3nMAssay Description:Average Binding Constant for CLK2; NA=Not Active at 10 uMMore data for this Ligand-Target Pair
Affinity DataKd: 190nMAssay Description:Average Binding Constant for CLK2; NA=Not Active at 10 uMMore data for this Ligand-Target Pair
Affinity DataKd: 470nMAssay Description:Average Binding Constant for CLK2; NA=Not Active at 10 uMMore data for this Ligand-Target Pair
Affinity DataKd: 1.40E+3nMAssay Description:Average Binding Constant for CLK2; NA=Not Active at 10 uMMore data for this Ligand-Target Pair
Affinity DataKd: 700nMAssay Description:Average Binding Constant for CLK2; NA=Not Active at 10 uMMore data for this Ligand-Target Pair
Affinity DataKd: 2.10nMAssay Description:Binding affinity to CLK2 (unknown origin) assessed as dissociation constant by competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKd: 82nMAssay Description:Binding affinity to CLK2 (unknown origin) assessed as dissociation constant by competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKd: 64nMAssay Description:Binding affinity to CLK2 (unknown origin) assessed as dissociation constant by competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKd: 36nMAssay Description:Binding affinity to CLK2 (unknown origin) assessed as dissociation constant by competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKd: 68nMAssay Description:Binding affinity to CLK2 (unknown origin) assessed as dissociation constant by competitive binding assayMore data for this Ligand-Target Pair
Affinity DataKd: 10nMAssay Description:Binding affinity to human CLK2More data for this Ligand-Target Pair
Affinity DataKd: 95nMAssay Description:Binding affinity to Clk2 assessed as dissociation constantMore data for this Ligand-Target Pair
Affinity DataKd: 680nMAssay Description:Binding affinity to Clk2 assessed as dissociation constantMore data for this Ligand-Target Pair
Affinity DataKd: 860nMAssay Description:Binding affinity to CLK2More data for this Ligand-Target Pair
Affinity DataKd: 44nMAssay Description:Binding affinity to CLK2More data for this Ligand-Target Pair
Affinity DataKd: >1.00E+4nMAssay Description:Binding affinity to CLK2More data for this Ligand-Target Pair
Affinity DataKd: >1.00E+4nMAssay Description:Binding affinity to CLK2More data for this Ligand-Target Pair
Affinity DataKd: >1.00E+4nMAssay Description:Binding affinity to CLK2More data for this Ligand-Target Pair
Affinity DataKd: >1.00E+4nMAssay Description:Binding affinity to CLK2More data for this Ligand-Target Pair
Affinity DataKd: 20nMAssay Description:Binding affinity to CLK2More data for this Ligand-Target Pair
Affinity DataKd: 320nMAssay Description:Binding affinity to human Clk2 More data for this Ligand-Target Pair
Affinity DataKd: 380nMAssay Description:Binding affinity to human Clk2 More data for this Ligand-Target Pair
Affinity DataKd: 59nMAssay Description:Binding affinity to human Clk2 More data for this Ligand-Target Pair




















3D Structure (crystal)






















